BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 1, 2020
Distillery Therapeutics

Calcium channel-targeting peptide to prevent hypertrophic cardiomyopathy

DISEASE CATEGORY: Cardiovascular
INDICATION: Cardiomyopathy A peptide targeting the cardiac calcium channel L-type α-interaction domain, a cytoplasmic portion the channel’s
BioCentury | Nov 14, 2013
Distillery Therapeutics

Indication: Cardiovascular disease

BioCentury | Aug 24, 2009
Company News

Prolias sales and marketing update

Items per page:
1 - 3 of 3